Skip to main content
. 2017 Feb 23;16:27. doi: 10.1186/s12933-017-0503-0

Fig. 3.

Fig. 3

Treatment effect. The figure displays the treatment effect (β-coefficient and SE) of vildagliptin (treating glibenclamide as reference group) on EPC number (a) and SDF-1α levels (b) in repeated measure GLM models after adjustment for baseline values. (*p < 0.05; **p < 0.01)